1997
DOI: 10.1074/jbc.272.26.16274
|View full text |Cite
|
Sign up to set email alerts
|

Close Association of the First and Fourth Extracellular Domains of the Duffy Antigen/Receptor for Chemokines by a Disulfide Bond Is Required for Ligand Binding

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

3
52
0
2

Year Published

1999
1999
2017
2017

Publication Types

Select...
6
3
1

Relationship

0
10

Authors

Journals

citations
Cited by 67 publications
(57 citation statements)
references
References 36 publications
3
52
0
2
Order By: Relevance
“…In addition, the epitopes for inhibitory mAbs 2D10, 2H2, and 2C6 in SD3 suggest that a secondary receptor-binding event may occur between DARC and DBP-II outside of previously identified primary DARC-binding sites in SD2 (18,19). The tail end of SD3 may contact extracellular loops linking the seven transmembrane regions of DARC that may play a role in DBP binding (51).…”
Section: Discussionmentioning
confidence: 99%
“…In addition, the epitopes for inhibitory mAbs 2D10, 2H2, and 2C6 in SD3 suggest that a secondary receptor-binding event may occur between DARC and DBP-II outside of previously identified primary DARC-binding sites in SD2 (18,19). The tail end of SD3 may contact extracellular loops linking the seven transmembrane regions of DARC that may play a role in DBP binding (51).…”
Section: Discussionmentioning
confidence: 99%
“…Our preliminary studies show that CXCL4 displaces histones from the DNA within neutrophil extravascular traps, which may injure the pulmonary vasculature and the adjacent epithelial barrier (53,54). Alternatively, binding of CXCL4 to cell-surface glycosaminoglycans (55) might compete with CXCL7, CXCL5, and other CXC chemokines for binding to Duffy antigen/receptor for chemokines (56), thereby impairing their removal from sites of inflammation (22). This model would be consistent with the reported role of CXCL5 in ALI (34) and would help explain how overexpression of CXCL4 can substitute for the absence of CXCL7, notwithstanding the differences in their effects on attracting and activating neutrophils to the injured lung.…”
Section: /Cxcl7mentioning
confidence: 99%
“…Affinities with DARC natural ligand, CXCL8, and different antibodies [33,[51][52][53][54][55][56][57][58] confirmed predictions made about DARC topology [59]. This transmembrane protein as bona fide GPCR has 7 transmembrane segments with four extracellular loops (named Extra Cellular Domains or ECDs) and four intracellular loops (named Intra Cellular Domains or ICDs).…”
Section: The Different Aspects Of the Researchmentioning
confidence: 80%